JP6118392B2 - 非麻薬性鎮痛作用を有する合成ペプチド - Google Patents

非麻薬性鎮痛作用を有する合成ペプチド Download PDF

Info

Publication number
JP6118392B2
JP6118392B2 JP2015501616A JP2015501616A JP6118392B2 JP 6118392 B2 JP6118392 B2 JP 6118392B2 JP 2015501616 A JP2015501616 A JP 2015501616A JP 2015501616 A JP2015501616 A JP 2015501616A JP 6118392 B2 JP6118392 B2 JP 6118392B2
Authority
JP
Japan
Prior art keywords
peptide
amino acids
amino acid
ala
substitution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2015501616A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015512385A (ja
Inventor
ペトロヴィチ ヴラーソフ，ゲンナジー
ペトロヴィチ ヴラーソフ，ゲンナジー
ミハイロヴィチ コチン，アルカディー
ミハイロヴィチ コチン，アルカディー
Original Assignee
コチン，オレク アルカーディエヴィチ
コチン，オレク アルカーディエヴィチ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by コチン，オレク アルカーディエヴィチ, コチン，オレク アルカーディエヴィチ filed Critical コチン，オレク アルカーディエヴィチ
Publication of JP2015512385A publication Critical patent/JP2015512385A/ja
Application granted granted Critical
Publication of JP6118392B2 publication Critical patent/JP6118392B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
JP2015501616A 2012-03-22 2012-12-07 非麻薬性鎮痛作用を有する合成ペプチド Active JP6118392B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
RU2012110908 2012-03-22
RU2012110908/10A RU2508295C2 (ru) 2012-03-22 2012-03-22 Синтетические пептиды с ненаркотическим типом анальгетического действия
PCT/RU2012/001036 WO2013141750A1 (ru) 2012-03-22 2012-12-07 Синтетические пептиды с ненаркотическим типом анальгетического действия

Publications (2)

Publication Number Publication Date
JP2015512385A JP2015512385A (ja) 2015-04-27
JP6118392B2 true JP6118392B2 (ja) 2017-04-19

Family

ID=49223070

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015501616A Active JP6118392B2 (ja) 2012-03-22 2012-12-07 非麻薬性鎮痛作用を有する合成ペプチド

Country Status (8)

Country Link
US (1) US9260482B2 (https=)
EP (1) EP2848629B1 (https=)
JP (1) JP6118392B2 (https=)
CA (1) CA2867994C (https=)
ES (1) ES2651265T3 (https=)
IN (1) IN2014MN02080A (https=)
RU (1) RU2508295C2 (https=)
WO (1) WO2013141750A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014367781B2 (en) * 2013-12-19 2019-07-04 Eisai R&D Management Co., Ltd. Therapeutic and/or preventive agent comprising 1-indansulfamide derivative for pain
DE102016125645A1 (de) 2016-12-23 2018-06-28 Forschungszentrum Jülich GmbH D-enantiomere Peptide zur Therapie von chronischem und neuropathischem Schmerz
RU2651491C1 (ru) 2017-04-07 2018-04-19 Общество с ограниченной ответственностью "Биофармокс" Специфические пептидные ингибиторы клатрина
US20210228677A1 (en) * 2020-01-28 2021-07-29 Pharmbiotech OY Pharmaceutical composition and a method for its manufacture

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1229658B (it) 1989-04-21 1991-09-06 Eniricerche Spa Analoghi della timopentina retro-inversi ad uno o piu' legami, il metodo per la loro sintesi ed il loro impiego per la preparazione di composizioni farmaceutiche.
US5175146A (en) * 1989-12-05 1992-12-29 Vical, Inc. Synthetic calcitonin peptides

Also Published As

Publication number Publication date
EP2848629A4 (en) 2016-03-02
US9260482B2 (en) 2016-02-16
CA2867994A1 (en) 2013-09-26
JP2015512385A (ja) 2015-04-27
EP2848629B1 (en) 2017-09-06
CA2867994C (en) 2017-05-16
WO2013141750A1 (ru) 2013-09-26
RU2508295C2 (ru) 2014-02-27
ES2651265T3 (es) 2018-01-25
US20150073123A1 (en) 2015-03-12
IN2014MN02080A (https=) 2015-08-21
RU2012110908A (ru) 2013-09-27
EP2848629A1 (en) 2015-03-18

Similar Documents

Publication Publication Date Title
TWI670281B (zh) Ｇｉｐ－ｇｌｐ－１雙重促效劑化合物及方法
CN103596972B (zh) 多肽
TWI221845B (en) Peptide analogues
US20240293511A1 (en) Hepcidin mimetics for treatment of hereditary hemochromatosis
IE913582A1 (en) Cyclopeptides
JP6118392B2 (ja) 非麻薬性鎮痛作用を有する合成ペプチド
CN102958533A (zh) 二肽连接的药剂
TW200412995A (en) Peptide YY analogs
McGregor et al. Potent analgesic activity of the enkephalin-like tetrapeptide H-Tyr-D-Ala-Gly-Phe-NH2
JP2002530432A (ja) Ｇｈ−ｒｈ阻害ｉｇｆ−ｉおよびｉｉの拮抗類似体
AU685292B2 (en) Tri-, tetra-, penta-, and polypeptides and their therapeutic use as a n antidepressant agent
CZ91497A3 (en) Peptides and pharmaceutical preparations containing thereof
JP6952320B2 (ja) 新規ｎｋ３受容体アゴニスト
AU677324B2 (en) Motilin-like polypeptides with gastrointestinal motor stimulating activity
FI95273C (fi) Menetelmä kipua lievittävien peptidien, niiden amidien ja suolojen valmistamiseksi
US20080009448A1 (en) Peptide Derivative
EP4658674A1 (en) Gip/glp1/gcg tri-receptor agonists and uses thereof
KR20070083815A (ko) 고체상 합성에서 ｓ-알킬-술페닐 보호기
CA2425804A1 (en) Urotensin-ii agonists and antagonists
US11041010B2 (en) Hybrid peptidomimetics for use in neuropathic pain
JPH06509571A (ja) タキキニン拮抗薬としての環状ヘキサペプチドの製法およびその薬学的化合物
TW202511281A (zh) 抗病毒多肽類似物
WO1996030405A1 (en) Peptides with growth promotion properties
WO2014075137A1 (en) Peptides incorporating amino-substituted lactams for treatment of retinopathy
HK40100630A (zh) 抗病毒多肽类似物

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20151130

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20161107

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170127

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20170228

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20170324

R150 Certificate of patent or registration of utility model

Ref document number: 6118392

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250